Company: SXTPW
Filing Date: 2025-07-07
Form Type: S-1
Source: 0001213900-25-061842
Chunk: 69

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-07
Form: S-1
Chunk 69
---
 other offerings, no stockholder rights plans, no material nonpublic information, use of proceeds, indemnification of purchasers, reservation and listing of shares of common stock, and no subsequent equity sales for 45 days, subject to certain exceptions. |

The securities will be
offered at a fixed combined public offering price and are expected to be issued in a single closing. We expect this offering to be completed
on or about July 14, 2025.

We expect to deliver
the shares and securities to the purchasers in the offering on or about July 14, 2025, subject to satisfaction of certain conditions.

Fees and Expenses

The following table shows
per share and accompanying Warrants and per Pre-Funded Warrant and accompanying Warrants placement agent fees and total placement
agent fees we will pay in connection with the sale of the securities in this offering.

| Per share and Common Warrants placement agent cash fees              |     | $ |
| Per Pre-Funded Warrant and Common Warrants placement agent cash fees |     | $ |
| Total                                                                |     | $ |

We have agreed to pay the placement agent a total cash fee equal to 7.5% of the gross proceeds of this offering and a management fee equal to 1.0% of the gross proceeds raised in this offering. We will also pay the placement agent a non-accountable expense allowance of $10,000, $5,000 for the expenses of its clearing firm, and will reimburse the placement agent for its road show expenses in addition to up to $100,000 to cover its legal fees and expenses. We estimate the total offering expenses of this offering that will be payable by us, excluding the placement agent’s fees and expenses, will be approximately $0.4 million. After deducting the placement agent’s fees and our estimated offering expenses, we expect the net proceeds from this offering to be approximately $4.2 million.

<div align='center'>34</div>

Placement Agent Warrants

We have agreed to grant
Placement Agent Warrants to the placement agent or its designees to purchase a number of shares of our common stock equal to 5% of the
aggregate number of shares of common stock and Pre-Funded Warrants sold to the investors in this offering. The Placement Agent Warrants
will have an exercise price equal to 125% of the combined public offering price per share of common stock and accompanying Warrants and
will terminate on the anniversary of commencement of sales in this offering. The other terms